Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D05LZV
|
|||
Drug Name |
Epoxysuccinate derivative 4
|
|||
Synonyms |
PMID25399719-Compound-21
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Company |
THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK THE BOARD OF TRUSTEES OF THE UNIVERSITY OF ILLINOIS
|
|||
Structure |
Download2D MOL |
|||
Formula |
C19H20FN3O5S
|
|||
Canonical SMILES |
CC(C)CC(C(=O)NC1=NC(=CS1)C2=CC=C(C=C2)F)NC(=O)C3C(O3)C(=O)O
|
|||
InChI |
1S/C19H20FN3O5S/c1-9(2)7-12(21-17(25)14-15(28-14)18(26)27)16(24)23-19-22-13(8-29-19)10-3-5-11(20)6-4-10/h3-6,8-9,12,14-15H,7H2,1-2H3,(H,21,25)(H,26,27)(H,22,23,24)/t12-,14-,15-/m0/s1
|
|||
InChIKey |
WVMZJHSGEWZNEO-QEJZJMRPSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Calpain-2 (CAPN2) | Target Info | Inhibitor | [1] |
Target's Patent Info | Calpain-2 (CAPN2) | Target's Patent Info | [1] | |
KEGG Pathway | Protein processing in endoplasmic reticulum | |||
Apoptosis | ||||
Alzheimer's disease | ||||
Reactome | Degradation of the extracellular matrix | |||
WikiPathways | Focal Adhesion | |||
Integrated Pancreatic Cancer Pathway | ||||
Alzheimers Disease | ||||
Integrin-mediated Cell Adhesion |
References | Top | |||
---|---|---|---|---|
REF 1 | An updated patent review of calpain inhibitors (2012 - 2014).Expert Opin Ther Pat. 2015 Jan;25(1):17-31. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.